UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Series A Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interests in Operating Subsidiaries	Treasury Stock, Common
Beginning balance (in shares) at Dec. 31, 2021		350,000
Beginning balance at Dec. 31, 2021		$ 14,753
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value		$ 1,151
Ending balance (in shares) at Mar. 31, 2022		350,000
Ending balance at Mar. 31, 2022		$ 15,904
Beginning balance (in shares) at Dec. 31, 2021			48,807,748
Beginning balance at Dec. 31, 2021	$ 430,475		$ 49	$ 648,389	$ (181,724)	$ 11,042	$ (47,281)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(73,266)				(73,266)	0
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	(1,151)			(1,151)
Dividend on Series A Redeemable Convertible Preferred Stock	(700)			(700)
Issuance of common stock for vesting of restricted stock units (in shares)			15,000
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			292,667
Compensation expense for share-based awards	1,174			1,174
Repurchase of common stock (in shares)			(2,341,715)
Repurchase of common stock	(10,988)		$ (2)				(10,986)
Ending balance (in shares) at Mar. 31, 2022			46,754,930
Ending balance at Mar. 31, 2022	345,472		$ 47	647,640	(254,990)	11,042	(58,267)
Beginning balance (in shares) at Dec. 31, 2022		350,000
Beginning balance at Dec. 31, 2022		$ 19,924
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value		$ 1,554
Ending balance (in shares) at Mar. 31, 2023		350,000
Ending balance at Mar. 31, 2023		$ 21,478
Beginning balance (in shares) at Dec. 31, 2022			43,484,867
Beginning balance at Dec. 31, 2022	269,322		$ 43	663,284	(306,789)	11,042	(98,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	9,447				9,447	0
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	(1,554)			(1,554)
Dividend on Series A Redeemable Convertible Preferred Stock	(700)			(700)
Issuance of common stock from the Rights Offering, Shares			15,068,753
Issuance of common stock for vesting of restricted stock units (in shares)			110,541
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)			(17,500)
Shares withheld related to net share settlement of share-based awards (in shares)			(94,863)
Shares withheld related to net share settlement of share-based awards	(416)			(416)
Rights Offering	79,111		$ 15	79,096
Compensation expense for share-based awards	477			477
Ending balance (in shares) at Mar. 31, 2023			58,551,798
Ending balance at Mar. 31, 2023	$ 355,687		$ 58	$ 740,187	$ (297,342)	$ 11,042	$ (98,258)